Agile Clinical Trials

03/07/2023

This study will look at an investigational medication to see how safe it is and whether it works for the treatment of moderate to severe Crohn’s disease (CD). Patients who complete the study can continue into a longterm extension study. About 265 patients are expected to take part in the study.

Why is this study important?
CD is a condition that causes inflammation in the digestive tract. There are multiple treatments available for people with CD. However, for some people, these treatments do not work, only partly work, stop working over time, or are not tolerated. Therefore, there is a need for alternative treatment options.

03/07/2023

Agile is enrolling child-bearing women between the ages of 14 and 35 in an investigational oral contraceptive clinical study. Qualified subjects will receive up to $450 in financial compensation.

Qualified participants:
• are premenopausal women in good physical and mental health
• do not want to have children at least one year following screening
• meet other study criteria
Qualified participants will receive at no cost:
• all study-related medical exams
• lab tests
• investigational oral contraceptive
Reimbursement for time and study-related travel is available. Insurance is not required.

02/15/2023

Clinical Study for a postmenopausal woman between the ages of 40 and 75, experiencing pain during sexual in*******se?
If so, you may be eligible to participate in a clinical research study.
Qualified participants will receive study-related exams, lab tests and study vaginal inserts or placebo at no cost.
If you are able to attend 3 visits and are willing to remain sexually active during the study,

Qualified subjects will receive up to $300

Please call Agile Clinical Research Trials, LLC
at 404.806.9681.

02/15/2023

Crohn's Disease study looking for qualified patients. Who can take part?
You, or someone you care for, may be able to take part if you/they:
• are 18–75 years of age
• have been diagnosed with CD for at least
3 months
• currently have CD symptoms.

02/15/2023

Crohn's Disease (CD) Clinical Study. This study will look at an investigational medication to see how safe it is and whether
it works for the treatment of moderate to severe Crohn’s disease (CD). Patients who complete the study can continue into a long-term extension study. Contact us: Agile at 404.806.9681 or

Diabetes Diabetes is a disease in which blood sugar (glucose) levels in your body are too high. Diabetes can cause serious health problems, including heart attack or stroke, blindness, problems during pregnancy, and kidney failure. About 15 million women in the United States have diabetes, or about....

11/04/2022

Paid study is to validate that changes in the design of
the U by Kotex® Click® Compact tampons - $375

11/04/2022

Could you be part of the next
vaccine breakthrough?

10/04/2022

10/04/2022

mRNA vaccines have changed the way we fight infectious diseases.

05/23/2022

Women's Birth Control Patch Study. The Luminous Research Study is for an investigational birth control patch for women who wish to use a skin patch to prevent pregnancy.

You may qualify for the Luminous Research Study if you:
• Are sexually active
• Are at least 16 years of age
• Have normal, regular menstrual cycles
• Wish to prevent pregnancy for at least 12 months
• Are willing to try an investigational hormonal method of birth control
• Are willing to use the study patch as your only method of birth control during the study.

12/07/2020

aims to develop a treatment that can prevent people with -19 from developing advanced disease that requires hospitalization. Learn more here!

12/06/2020

AGILE Clinical Research today announced the initiation of the Outpatient Monoclonal Antibodies and Other Therapies Trial, evaluating investigational agents to treat COVID-19. ACTIV-2 aims to develop a treatment that can prevent people with COVID-19 from developing advanced disease that requires hospitalization. People in the [insert city] area who have recently been diagnosed with COVID-19 are are not hospitalized have the opportunity to make a huge contribution by participating in ACTIV-2. See if you're eligible! https://agilecrt.com/current-studies.com. Call us: 404.806.9681